Verastem Oncology Has Initiated Its International Confirmatory Phase 3 RAMP 301 Trial Of Avutometinib And Defactinib Combo Versus Standard Chemotherapy Or Hormonal Therapy For Recurrent Low-grade Serous Ovarian Cancer
Author: Benzinga Newsdesk | December 13, 2023 08:02am